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Abstract
Here we report a stop-mutation in the BOD1 (Biorientation Defective 1) gene, which co-seg-
regates with intellectual disability in a large consanguineous family, where individuals that
are homozygous for the mutation have no detectable BOD1mRNA or protein. The BOD1
protein is required for proper chromosome segregation, regulating phosphorylation of PLK1
substrates by modulating Protein Phosphatase 2A (PP2A) activity during mitosis. We report
that fibroblast cell lines derived from homozygous BOD1mutation carriers show aberrant
localisation of the cell cycle kinase PLK1 and its phosphatase PP2A at mitotic kinetochores.
However, in contrast to the mitotic arrest observed in BOD1-siRNA treated HeLa cells,
patient-derived cells progressed through mitosis with no apparent segregation defects but
at an accelerated rate compared to controls. The relatively normal cell cycle progression
observed in cultured cells is in line with the absence of gross structural brain abnormalities
in the affected individuals. Moreover, we found that in normal adult brain tissues BOD1
expression is maintained at considerable levels, in contrast to PLK1 expression, and pro-
vide evidence for synaptic localization of Bod1 in murine neurons. These observations sug-
gest that BOD1 plays a cell cycle-independent role in the nervous system. To address this
possibility, we established two Drosophilamodels, where neuron-specific knockdown of
BOD1 caused pronounced learning deficits and significant abnormalities in synapse
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morphology. Together our results reveal novel postmitotic functions of BOD1 as well as
pathogenic mechanisms that strongly support a causative role of BOD1 deficiency in the
aetiology of intellectual disability. Moreover, by demonstrating its requirement for cognitive
function in humans and Drosophila we provide evidence for a conserved role of BOD1 in
the development and maintenance of cognitive features.
Author Summary
Intellectual disability (ID) is a form of cognitive impairment characterized by limitations
in cognitive functions that manifest as an intelligence quotient (IQ) below 70. ID has a
prevalence of 1–3% in the general population and represents a major health-care problem.
To understand the functional consequences of causative mutations we study the disease-
causing mechanisms of hereditary acquired mutations that result in ID. Here we describe
a large family that has a mutation affecting a gene called BOD1. Family members who are
homozygous for the mutation (i.e. both maternal and paternal copies of the gene carry the
mutation) produce no detectable BOD1 protein and suffer from intellectual disability. We
have previously shown that BOD1 is a crucial regulator of an important signalling mole-
cule called Protein Phosphatase 2A (PP2A) during cell division. PP2A also has diverse but
poorly understood roles in neuronal function. We demonstrate here that Bod1 can regu-
late PP2A function throughout the cell cycle and also localises to synapses in neurons. To
determine if BOD1 deficiency directly affects the structure and function of neurons we tar-
geted the gene in the model fly organism Drosophila Melanogaster. Neuron-specific
knockdown caused pronounced learning difficulties and significant abnormalities in syn-
aptic morphology indicating that BOD1 is involved in an evolutionary conserved mecha-
nism crucial for the development of cognitive features.
Introduction
Intellectual disability (ID) [1] is a form of cognitive impairment, characterized by limitations
in mental functioning that manifest as an intelligence quotient (IQ) below 70. ID has an esti-
mated prevalence ranging between 1% and 3% in the general population [2–4].Mutations in
more than 750 genes have been identified that cause ID when mutated [5], but particularly
autosomal recessive forms of ID (ARID) are poorly understood. Even though the count of
genes known to carry ARID causing mutations is now increasing at an accelerated rate because
of the recent broad implementation of high throughput sequencing technologies, there are to
date still less than 50 genes reported [4]. In order to increase the knowledge about the molecu-
lar basis of ARID, we have previously performed autozygosity mapping and mutation screen-
ing in a large cohort of Iranian families with a high percentage of consanguinity and identified
several loci implicated in non-syndromic ARID [6,7]. In addition, we have identified a diversity
of ARID genes involved in several physiological pathways, emphasising the genetic heterogene-
ity of the non-syndromic ARID phenotype [8–15].The diversity of genes involved in the aetiol-
ogy of ARID also reflects the complexity of the affected organ, i.e. the brain, so that an increase
in knowledge about monogenic causes of ID and their functional implications can greatly con-
tribute to a better understanding of the processes involved in the development and mainte-
nance of the brain and its higher cognitive functions.
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We report here on a family with 4 female individuals presenting with ID where we found a
single homozygous mutation disrupting the BOD1 (Biorientation Defective 1) gene. BOD1
encodes a highly conserved 22 kDa protein required for proper chromosome biorientation
[16]. According to the GTEx Portal (http://www.gtexportal.org/home/gene/BOD1; accessed on
10/02/16) BOD1mRNA is expressed in the vast majority of investigated tissues. During mitosis
BOD1 regulates Protein Phosphatase 2A (PP2A) activity at the kinetochore [17] by specifically
binding to and inhibiting PP2A complexes containing the B56 regulatory subunit. PP2A-B56
localises to mitotic kinetochores during mitosis and controls both kinetochore microtubule
attachment and checkpoint signalling [18–22]. Depletion of BOD1 from HeLa cells results in a
loss of inhibition of PP2A-B56 and subsequent increase of phosphatase activity at the kineto-
chore. In particular, BOD1 depletion leads to reduced phosphorylation of PBIP/CENP-U,
which results in a failure to recruit the mitotic Polo-Like Kinase 1 (PLK1) [MIM 602098] to
kinetochores [8].
Additionally, BOD1 may have other functions in cell and organism physiology. For exam-
ple, somatic deletions in BOD1 were previously found in non-pyramidal neurons and cells in
white matter from patients with Schizophrenia [23]. Moreover, it has recently been described
to interact with the SET1/MLL (SET Domain Containing 1A/Mixed-Lineage Leukemia) com-
plex, a member of the COMPASS-like H3K3 histone methyltransferase multi-subunit com-
plexes. To date, no defects in histone methylation have been linked to BOD1. However, SET1/
MLL also contains HCFC1 (Host Cell Factor C1) [MIM 309541] [24], a protein previously
implicated in X-linked ID [25,26].
In this report, we describe the consequences of BOD1 deficiency using cell lines derived
from fibroblasts of affected individuals. We found that these show changes in PLK1 protein
levels, function and mislocalization of PLK1 and PP2A but, unexpectedly, with no associated
mitotic impairments. This observation, which is in agreement with an absence of microcephaly
in individuals with BOD1 mutations, raised the possibility of a so far unidentified, cell cycle-
independent role for BOD1. In support of this hypothesis we provide evidence for a presynap-
tic localization of BOD1 in mammalian neurons and show that neuron-specific knockdown of
the Drosophila ortholog of BOD1 leads to abnormal learning and affects synaptic morphology.
Taken together, our findings strongly support the causative role of the BOD1mutation in the
individuals affected by ID, uncover novel aspects of BOD1 function and pathogenic mecha-
nisms and highlight an evolutionarily conserved role of BOD1 in cognition.
Results
A nonsense mutation in BOD1 co-segregates with ID in a
consanguineous Iranian family with four affected individuals
In a family with 4 female individuals with ID (Fig 1A) we performed multipoint linkage analy-
sis based on the assumption of an autosomal recessive pattern of inheritance and a disease
allele frequency of 0.001. We identified a single 4.3 Mbp interval on chromosome 5q (5q35.1–
35.2) with a LOD score of 4.4 (S1 Fig) and sequenced the coding regions of all protein coding
genes within the interval. This revealed a homozygous point mutation (NM_138369.2:
c.334C>T; p.R112X) in the second exon of the BOD1 gene, which co-segregated with the dis-
ease (Fig 1A). The mutation was not found in 380 Iranian and 340 German control chromo-
somes and was absent in 200 Danish exomes [27]. In addition, the NM_138369.2:c.334C>T
mutation was not found in the current data release (ESP6500SI-V2) of the Exome Variant
Server (http://evs.gs.washington.edu/EVS/), NHLBI GO Exome Sequencing Project (ESP),
Seattle, WA (accessed June 2015), containing exome sequencing results from 6503 individuals,
nor in data from the 1000 Genomes Project [28], nor in the Exome sequencing Results from
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60,706 unrelated individuals compiled by the Exome Aggregation Consortium (ExAC), Cam-
bridge, MA (http://exac.broadinstitute.org, accessed February 2016). Moreover, our sequencing
of controls and database search also revealed no other homozygous deleterious mutations in
other parts of the BOD1 coding region.
The three affected females of the left branch of the family pedigree (V:2; V:3; V:6) suffered
from moderate ID with an IQ of 50–55 (determined by Wechsler’s scale) in all three cases. In
addition, these individuals presented with either primary (V:3) or secondary (V:2; V:6) ame-
norrhoea of unknown cause. Endocrinological tests and ultrasound investigations of the ova-
ries revealed no abnormalities. The affected individual in the right branch of the family
Fig 1. NonsenseMutation in BOD1 co-segregates with Intellectual Disability and leads to loss of BOD1 in patient tissues. (A) Family pedigree and
co-segregation of the mutation within the family. Filled symbols represent affected individuals. Sequence chromatograms from one patient (V:2) and one
parent (IV:1) are shown on the upper right. (B) Schematic representation of BOD1 (black) and the exon composition in alternative transcripts. Previously
unknown transcripts are shown in green. Arrows indicate the location of primers used for RT-PCR experiments (C) Agarose Gel electrophoresis results of
RT-PCR experiment. (D) qRT-PCRwas performed on patient and control Fibroblasts. The experiments were performed twice with independent cells,
each time in triplicate (Error bars represent the SEM). One representative result is shown. (E) NMD analyses of patient fibroblasts were performed twice
with independent cell samples, each time in triplicate. The results are from pooled patient (BOD1-/-) and control (WT) samples. CHX: cycloheximide,
DMSO:Dimethyl sulfoxide. Error bars represent the SEM. (F) Western blot of protein extracts from fibroblast cells using a Bod1 polyclonal antibody. The
Bod1 antibody recognizes a 22KDa protein, matching the full-length Bod1 protein. Alpha tubulin was used as a loading control.
doi:10.1371/journal.pgen.1006022.g001
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pedigree (VI:1) presented with mild ID (IQ: 70–75). Brain MRI scans were performed on all
four affected individuals, but revealed no consistent morphological abnormalities. All four
individuals were obese or overweight but this phenotype did not co-segregate with the BOD1
mutation. From patient V:2 we obtained a lymphoblast cell line (LCL). In addition we were
able to establish fibroblast cell lines from affected individuals V:2 and V:3. Cells derived from
homozygous mutation carriers will be referred to as BOD1-/- cells throughout the manuscript.
RT-PCR and sequencing analyses of control fibroblasts showed the presence of the full length
BOD1 transcript (NM_138369.2), comprising all exons (1–4), represents the main isoform of the
protein, which is 185 amino acids long and most likely its dominant functional form. In addition
we detected three comparatively weakly expressed additional transcripts (Fig 1B and 1C), com-
posed of the exons 1+3+4 (isoform b, NM_001159651.1, comprising 129 amino acids), 1+2+4
(ENST00000285908.5, encoding 129 amino acids) and 1+4 (ENST00000480951, encoding 85
amino acids). Quantitative PCR analyses of RNA preparations from control and BOD1-/- cell
lines further revealed that BOD1mRNAwas absent in cell lines from both affected individuals
(Fig 1D). This loss of BOD1mRNA is likely caused by nonsense mediated decay (NMD) as
mRNA levels of 3 of the 4 detected splice variants were increased to near-control levels following
treatment with cycloheximide (Fig 1E). To confirm the loss of the main BOD1 isoform at the
protein level, we investigated the patient cell lines by western blot, using a rabbit polyclonal anti-
body raised against recombinant full length GST-BOD1 [16]. In keeping with our quantitative
PCR-results, this isoform was not detected in either BOD1-/- cell line (Fig 1F).
BOD1-/- fibroblasts progress through mitosis at an accelerated rate
We have previously reported that siRNA-mediated knockdown of BOD1 in HeLa cells pro-
duces profound chromosome biorientation defects and a block in mitotic segregation [16]. We
therefore set out to determine whether abnormalities in cell cycle progression occur in cell
lines derived from BOD1-/- individuals. We first examined cell cycle progression in WT and
BOD1-/- fibroblast cells (Fig 2A). This revealed a significant increase in the G1 population in
BOD1-/- cells compared to WT. Treating WT fibroblasts with BOD1 siRNA resulted in a simi-
lar accumulation of cells in G1 (Fig 1A and 1B) suggesting this change in cell cycle distribution
is directly due to loss of BOD1. We observed no mitotic figures in WT fibroblast cells depleted
of BOD1 by siRNA, suggesting that any cells with fully replicated DNA in Fig 2A were in G2.
In contrast, mitotic cells could be observed in BOD1-/- cells suggesting these cells are capable of
progressing through the cell cycle, but with a delay in progressing out of G1.
To detect any gross defects in mitotic chromosome segregation, we next examined the
mitotic timing of BOD1-/-and control WT fibroblasts using DIC time-lapse microscopy, mea-
suring the time from nuclear envelope breakdown (NEB) to anaphase onset (Fig 2C; see Meth-
ods). BOD1-/- fibroblasts progressed through mitosis rapidly, with 50% of cells completing
mitosis in 20 min compared to 30 min for the control cells (Fig 2D). Similar results were
obtained for BOD1-/- LCL cells (S2A Fig).
Examination of fixed BOD1-/- fibroblasts by immunofluorescence revealed no significant
increase in cells with unaligned or malformed spindles (S2B Fig), suggesting only a subtle dis-
turbance of mitotic regulation in these cells. This is surprising given the profound biorientation
defects observed in BOD1-depleted HeLa cells. We therefore explored the properties of mitotic
BOD1-/- cells in more detail.
BOD1-/- fibroblasts show mislocalisation of PLK1 and PP2A
Bod1 is required for proper chromosome alignment during mitosis and the proper phosphory-
lation of several substrates of the PLK1 and Aurora B (AURKB [MIM 604970]) protein kinases.
BOD1 Is Required for Cognition
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This effect occurs through the modulation of PP2A-B56 activity [16]. To determine if these
pathways were affected in BOD1-/- cell lines, we investigated the localisation of PP2A-B56 and
PLK1. In agreement with previously published observations in BOD1-depleted HeLa cells,
BOD1-/- fibroblasts had increased levels of PP2A-B56 at kinetochores (Fig 2E and 2F). Further-
more, PLK1 levels were reduced at the kinetochores of BOD1-/- cells compared to control fibro-
blasts (Fig 2G–2I), just as in Bod1-depleted HeLa cells. However, unlike BOD1 depleted HeLa
cells, BOD1-/- fibroblasts had increased PLK1 concentrations at centrosomes.
We also observed that total PLK1 protein levels were reduced in asynchronous BOD1-/-
fibroblasts (Fig 2J).However, when these cells were synchronised in mitosis using the Eg5
inhibitor Monastrol they exhibited PLK1 levels that were comparable to control fibroblasts
(Fig 2K).
To determine if the changes in protein stability of PLK1 were limited to BOD1-/- cell lines,
we performed siRNA-mediated knock down of BOD1 in wild-type primary fibroblasts. The
reduction in PLK1 levels was even more pronounced than that observed in BOD1-/- cells with
little or no detectable PLK1 protein (Fig 2L). PLK1 protein levels were partially recovered by
co-depletion of BOD1 and PP2A-B56 (Fig 2L) suggesting that Bod1 inhibits PP2A mediated
PLK1 destabilisation and that PP2A regulates PLK1 function throughout the cell cycle.
Since WT fibroblasts depleted of BOD1 do not enter mitosis, we next tested whether BOD1
has any role in mitosis in WT primary fibroblasts. We used immunofluorescence to localise
endogenous Bod1 and observed prominent localisation to mitotic centrosomes and kineto-
chores (Fig 2M), suggesting that a mitotic function for Bod1 is present in these cells, but is
masked in siRNA studies by an additional pathway in primary fibroblasts that results in G1
arrest. This G1 pathway is likely lost in highly transformed HeLa cells. To ensure the arrest was
not limited to fibroblast cells, we depleted Bod1 from immortalised, non-transformed RPE1
cells and also observed a G1 arrest (S2C Fig). Once more, localisation of BOD1 to kinetochores
and centrosomes was observed in untransfected RPE1 cells (S2D Fig), suggesting multiple
roles for BOD1 throughout the cell cycle.
To check the specificity of the Bod1 siRNA, we rescued Bod1 depletion with plasmids
expressing WT or constitutively active Bod1 [17] and observed rescue of PLK1 protein levels
(Fig 2N) confirming the specificity of the effect on PLK1 by Bod1 siRNA. We conclude that
BOD1 depletion in primary cells causes loss of PLK1 and that BOD1-/- fibroblasts stabilise suf-
ficient Plk1 to successfully progress through the cell cycle.
Fig 2. Functional consequences of the absence of BOD1 in patient-derived fibroblasts. (A) Flow cytometric analysis of cell cycle
profile in WT and BOD1-/- primary fibroblasts electroporated with control or BOD1 siRNA. Error bars represent standard deviation. (B)
Immunoblotting of BOD1 and tubulin from cell lysates simultaneously electroporated with samples analysed in (A). (C) Representative
DIC timelapse imaging of primary fibroblast cells undergoing mitosis. Nuclear Envelope Breakdown (NEB) and Anaphase Onset (AO)
are indicated. (D) Cumulative timing of NEB to AO timing in Primary Fibroblast cell lines. Error bars represent standard deviation.
P<0.001 for BOD1-/- cells to eachWT sample. Insufficient data collected for BOD1-/- cells to determine statistical significance. (E)
Immunofluorescence localization of PP2A-B56 in WT and BOD1-/- Primary fibroblasts. DAPI (blue), centromeres (detected with ACA)
(green), anti-PP2A-B56α (red). (F) Mean B56α levels at kinetochores of WT and BOD1-/- Primary fibroblasts (P<0.001). Error bars
represent SEM. (G) Immunofluorescence localization of PLK1 in WT and BOD1-/- Primary fibroblasts. DAPI (white), anti-PLK1
(green), ACA (blue). (H-J) Mean PLK1 levels at kinetochores and centrosomes of WT and BOD1-/- Primary fibroblasts, respectively
(P<0.001 in each instance). Error bars represent SEM. (K) Immunoblotting of PLK1, BOD1 and tubulin in asynchronousWT and
BOD1-/- primary fibroblasts. (L) Immunoblotting of PLK1, BOD1 and tubulin in asynchronous and Monastrol arrestedWT and BOD1-/-
Primary fibroblasts. (M) Immunofluorescence localization of Bod1 in WT Primary Fibroblasts. DAPI (white), ACA (blue), anti-Plk1
(red), anti-Bod1 (green). Scale = 5 μm. Inset shows a single bioriented kinetochore pair. (N) Immunoblotting of PP2A-B56δ, PLK1 and
tubulin in WT primary fibroblast electroporated with indicated combinations of CTR, B56-pool or BOD1 siRNA. Rescue of WT primary
fibroblasts after siRNA depletion of Bod1 with plasmids expressing GFP fused to either siRNA resistant WT Bod1 or Bod1T95E. (O)
Mitotic profile of WT primary fibroblasts and BOD1-/- fibroblasts 1 hr after release from RO 3306 into the indicated concentrations of BI
2536. Results show average of three independent experiments. A minimum of 100 mitotic cells counted per condition per experiment.
Error bars represent SEM.
doi:10.1371/journal.pgen.1006022.g002
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Changes in PLK1 function in BOD1-/- cells
Since BOD1-/- cells are able to propagate and progress through the cell cycle, we hypothesised that
they must have modulated the function of PLK1 to adapt to the presence of reduced PLK1 levels
during interphase (Fig 2J). To test this hypothesis, we arrested cells at the G2/M boundary, where
PLK1 is required for progression into M phase using RO3306, a CDK1 inhibitor. We then
released cells into fresh medium containing increasing amounts of the specific PLK1 inhibitor
BI2536. This assay uses the formation of bipolar mitotic spindles as a reporter of PLK1 function
[17]. Control WT fibroblasts exposed to BI2536 showed a reduced number of bipolar metaphase
spindles and an increased number of monopolar spindles as the concentration of BI2536 was
increased (Fig 2O). By contrast, BOD1-/- cells showed fewer monopolar spindles and only a small
reduction in the frequency of bipolar spindles even at the highest concentrations of BI2536. This
result suggests that BOD1-/- cells are hyposensitive to PLK1 inhibition relative toWT controls and
that they have adapted to loss of BOD1 by either increasing or bypassing PLK1 function. Consis-
tent with the former hypothesis, BOD1-/- cells have increased levels of PLK1 at centrosomes (Fig
2G and 2I), a critical location for PLK1 function in centrosome and spindle maturation.
These results suggest that despite an overall reduction in PLK1 levels in BOD1-/- cells, they
have nonetheless adapted and progress through mitosis in a relatively normal manner. This
conclusion is in line with our observation that homozygous mutation carriers do not show any
gross developmental or structural brain abnormalities, as are often found in individuals
affected by ID with mutations in proteins required for centrosome positioning and localisation
(see e.g. Chavali et al. [29] or Kuijpers & Hoogenraad [30]). We therefore hypothesized that
cognitive impairment caused by BOD1 deficiency might result from the disturbance of a differ-
ent, possibly brain-specific functional aspect of BOD1.
BOD1 expression is maintained in postmitotic brain tissues
Quantitative PCR of RNA from different regions of normal human fetal and adult brain
showed that all four BOD1 splice variants detected in lymphocytes and fibroblasts are present
throughout the brain, at both investigated developmental stages (Fig 3A).
To address whether BOD1 might exert functions independent from cell-cycle regulation of
PLK1, we compared BOD1 and PLK1 expression in different areas of the human brain by
RNA-sequencing. In agreement with the low rates of dividing cells in these terminally differen-
tiated tissues our results show that PLK1 expression drops to very low levels (Fig 3B) as com-
pared to the expression rates observed in pluripotent cells. BOD1 expression, however, is
maintained in most investigated brain tissues at about 20% of the expression levels observed in
pluripotent cells, strongly suggesting that BOD1 plays a PLK1- and cell cycle-independent role
in postmitotic brain cells.
BOD1 shows synaptic localization in mammalian neurons
Continuing on from the gene expression analysis we were interested in determining BOD1
localisation in mammalian neurons. We analysed murine corticoneuronal cells that were trans-
fected with BOD1-GFP,at short incubation time (7h, to avoid overexpression artefacts). We
observed a striking punctuate pattern with BOD1-GFP that co-localised with the synaptic
marker Bassoon (Fig 4), which suggests a potential role for Bod1 in synaptic signalling.
BOD1 is required in postmitotic neurons for learning
To experimentally address whether BOD1 is required directly in neurons for cognitive pro-
cesses, we took advantage of established animal model for ID disorders, the fruit fly Drosophila
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melanogaster. The Drosophila genome encodes a single gene representing the human BOD1
protein family (BOD1, BOD1L1 and BOD1L2), termed CG5514. A multiple sequence align-
ment is shown as supplemental S3 Fig. From now on we refer to this so far uncharacterized
Drosophila gene as Bod1. We used the UAS-Gal4 system [31], the panneuronal promoter elav-
Gal4 and three inducible RNAi lines carrying different constructs (Bod1vdrc101981 Bod1vdrc4542,
and Bod1HMS00720) to knockdown Bod1 specifically in postmitotic neurons. We subjected
Bod1 panneuronal knockdown flies to a simple non-associative learning assay: the light-off
jump reflex habituation paradigm. In this paradigm, which has previously uncovered learning
defects in several Drosophilamodels of Intellectual Disability [32–34] and in classic learning
and memory mutants [35], flies are exposed to a repeated light off stimulus at 1 second inter-
vals. Wildtype (wt) flies quickly adapt to the repeated stimulus and gradually suppress their ini-
tial jump response as a result of non-associative learning. In our experiments, flies of all tested
genetic conditions showed high jump response towards the initial light-off stimulus, demon-
strating that they properly perceived the stimulus and that their startle response was not com-
promised. We found that Bod1 knockdown flies failed to habituate to the presented light-off
stimuli compared to their genetic background controls with normal Bod1 levels, and kept on
jumping at high levels throughout the entire course of the experiments (Fig 5). This learning
defect was consistent for two Vienna Drosophila Resource Center (VDRC) RNAi constructs,
as well as for a non-overlapping independent short siRNA TriP construct (Fig 5A, 5B and
5C). To assess the significance of the habituation defects in both Bod1 knockdown models,
flies were considered to have habituated once they failed to jump in five consecutive trials (no-
jump criterion). Habituation was quantified as the number of trials required to reach the no-
jump criterion (TTC, Trials to criterion). TTC of the Bod1 knockdown flies was 2.38–fold
(Bod1vdrc1105166, n = 143, p<0.001), 2.14-fold (Bod1vdrc27445, n = 93, p<0.001) and 1.95-fold
(Bod1HMS00720, n = 70, p<0,001) increased over their respective controls (Fig 5A’, 5B’ and
5C), revealing significant habituation defects in all three Bod1 Drosophilamodels.
Fig 3. Expression of BOD1 and PLK1 in human tissues. (A) BOD1-specific quantitative RT-PCR experiments were carried out in triplicates,
using RNA from the indicated tissues. All splice variants (indicated by the respective exon combinations) were investigated. Error bars represent
the SEM. (B) Expression levels i.e. reads per kilobase of transcript per million reads mapped (RPKM), corresponding to BOD1 (NM_138369.2)
and PLK1 (NM_005030.5) obtained by RNA-Sequencing of commercially available RNA-samples from different brain tissues, induced pluripotent
stem cells (IPSC) and human embryonic stem cells (hES).
doi:10.1371/journal.pgen.1006022.g003
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The efficacy of the utilised RNAi constructs was confirmed by qPCR on RNA isolated from
Drosophila 3rd instar larvae upon ubiquitously-induced knockdown. As Bod1vdrc27445 and
Bod1vdrc105166 contain almost identical siRNA hairpins, only Bod1vdrc105166-mediated knock-
down was assessed and revealed 23% remaining gene expression; p = 0.0012, student’s t-test;
supplemental S1 Table. Bod1HMS00720-mediated RNAi reduced levels of Bod1 to a lesser but
still very significant extend, resulting in 37% remaining gene expression (p = 0.0086, student’s
t-test; S1 Table).
We conclude that conditional knockdown of Bod1, induced specifically in neurons, does
not affect the overall startle response/acute fitness of the flies but leads to specific and highly
consistent learning defects.
Synapse biology is crucial for learning and has been proposed to play a central role in ID
[36–38]. Therefore, and because of the observed Bod1 localisation to synapses in cultured neu-
rons, we investigated the consequences of Bod1 knockdown on synapse development. The Dro-
sophila larval Neuromuscular junction (NMJ) was investigated in elav-Gal4 induced
panneuronal Bod1 knockdown larvae using an antibody against dlg1 that visualizes the overall
morphology of synaptic terminals. Knockdown of Bod1 with both Bod1vdrc27445 and
Bod1vdrc105166 lines induces modest but highly significant abnormalities in synapse branching
(Fig 5D)The average number of branching points was 2.7 versus 1.6 in the appropriate
genetic background control (Bod1vdrc105166 versus control); p<0.00001) and 2.5 versus 1.3
(Bod1vdrc27445 versus control; p<0.005). Other synaptic parameters such as length or perimeter
of the synaptic terminal were not consistently changed. There was no significant NMJ defect in
Fig 4. Presynaptic localisation of BOD1 in murine corticoneuronal cells.Representative indirect immunofluorescence
confocal image (LSM510) of mouse cortical neurons transfected at day 7 after preparation with 0.1μg BOD1-GFP for 7hrs. Arrows
indicate co-localization of BOD1-GFP (in green) with the (pre)synaptic marker anti-Bassoon (red). Insets are magnifications of the
boxed area. The range indicator (RI) shows that the images are not overexposed.
doi:10.1371/journal.pgen.1006022.g004
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Fig 5. Neuronal knockdown of Drosophila Bod1 affects learning and synapse development. (A-B') Knockdown of
Drosophila Bod1 using the postmitotic, pan-neuronal promoter elav-Gal4 and three inducible RNAi lines affects non-associative
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the weaker Bod1HMS00720 knockdown condition (1.5 in Bod1HMS00720 versus 1.4 in control).
We conclude that Bod1 is required for habituation and may control synaptic branching.
Discussion
We report that BOD1, a protein that has previously been linked to mitotic cell division, is
required for cognitive functions in humans and Drosophila. This is in line with a previous
report that described somatic deletions in BOD1 within non-pyramidal neurons and cells in
white matter from patients with Schizophrenia, implicating BOD1 as a player in brain develop-
ment and, more importantly, in a neuropsychiatric context [23].
In agreement with the absence of gross morphological brain abnormalities in homozygous
mutation carriers, our experiments, using neuronal cultures andDrosophila as a model organism,
support a novel postmitotic function for Bod1 and raise the possibility that abnormal synaptic
development or function contributes to cognitive impairment in individuals with BOD1mutations.
In the consanguineous family we describe here, a nonsense mutation in exon 2 of BOD1 co-
segregates with moderate-to-severe intellectual disability. This mutation is absent in ethnically
matched controls and in all presently accessible genome or exome sequencing data repositories.
Furthermore, it is of note that in the ExAC database, which contains exome sequencing data
from 60,706 unrelated individuals, only 6 coding positions within BOD1 showed deleterious
alterations, of which none was observed in a homozygous state and four were found only once.
This shows that homozygous deleterious mutations affecting BOD1 are not tolerated in intel-
lectually healthy individuals and strongly supports our conclusion that loss of BOD1 function
is detrimental to molecular pathways involving this protein and is thus causative for ID.
All four homozygous mutation carriers lack detectable levels of BOD1, presumably because
the mutation leads to NMD of the corresponding mRNA. Originally BOD1 was identified as a
centrosomal and kinetochore protein that is required for proper chromosome biorientation in
HeLa cells [16]. It has previously been shown that BOD1 is involved in the regulation of AuroraB
kinase dependent phosphorylation of Mitotic Centromere Associated Kinesin alias Kinesin Fam-
ily Member 2C (MCAK alias KIF2C [MIM 604538]) [16]. Recently BOD1 has also been shown
to act as an inhibitor of PP2A-B56 function at the kinetochore and to regulate the recruitment of
a number of proteins to the kinetochore and centrosome, including PLK1 and PP2A [17].
A considerable number of other centrosomal proteins or proteins required for centrosome
positioning and localisation have already been associated with ID, including ASPM [39], the
human ortholog of the abnormal spindle gene (asp) in Drosophila [40], which is essential for
the normal functioning of mitotic spindles [41]. Also defects inMCPH1 [MIM 607117],
CENPJ [MIM 609279] and CDK5RAP2 [MIM 608201] have been shown to cause ID (for
learning in the light-off jump habituation paradigm. Jump responses were induced by repeated light-off pulses for 100 trials with a
1s inter-trial interval. Bod1 knockdown flies of genotypes (A) UAS-Bod1vdrc105166/2xGMR-wIR; elav-Gal4, UAS-Dicer2/+, plotted
as red squares, (B) UAS-Bod1vdrc27445/2xGMR-wIR; elav-Gal4, UAS-Dicer2/+, plotted as blue squares, and (C) 2xGMR-wIR/+;
UAS-Bod1HMS00720/elav-Gal4, UAS-Dicer2, plotted as green squares, failed to habituate, i.e. to efficiently reduce their jump
response upon repeated stimulation. The genetic background controls, generated by crossing the driver line to the respective
genetic background of the RNAi line, are shown as grey circles (2xGMR-wIR/+; elav-Gal4, UAS-Dicer2/+). (A', B', C’)
Quantification of average jump responses revealed that all three mutant genotypes habituated significantly slower (*** p<0,001).
Red bar in (A') Bod1vdrc105166, TTC = 49.75, n = 143 versus controls: TTC = 20.88, n = 134. Blue bar in (B'): Bod1vdrc27445,
TTC = 61.92, n = 93 versus controls TTC = 28.93, n = 87. Green bar in (C)’ Bod1HMS00720, TTC = 10.03, n = 70 versus controls
TTC = 5.51, n = 68. (D) Knockdown of Drosophila Bod1 using the elav-Gal4 promoter and RNAi lines Bod1vdrc27445 and
Bod1vdrc105166 consistently affects synaptic branching at the Drosophila Neuromuscular Junction (see text). L3 muscle 4
synapses were labelled with anti-dlg1 and quantified using an in house-developed macro. A Bod1vdrc27445 (UAS-Bod1vdrc27445/
2xGMR-wIR; elav-Gal4, UAS-Dicer2/+) and control (2xGMR-wIR/+; elav-Gal4, UAS-Dicer2/+) synapse is shown. Top panel in
red: dlg1 labelling; bottom panels show the macro-annotated, quantified synapse). Asterisks highlight the increased number of
synaptic branching points at the mutant synaptic terminal.
doi:10.1371/journal.pgen.1006022.g005
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review see Chavali et al. or Bond et al. [29,42]). However, mutations in these genes usually
induce not only cognitive defects but also entail severe brain abnormalities such as primary
microcephaly. It is therefore remarkable that homozygous mutation carriers (despite the
apparent absence of the main BOD1 transcript) do not show microcephaly or any other gross
structural brain abnormalities. Therefore, as BOD1-/- fibroblasts still proliferate and pass
through mitosis, they must have in some way adapted to the loss of BOD1 and to BOD1-me-
diated PLK1 function, demonstrating a surprising adaptability in the cell cycle control machin-
ery and thus providing an explanation for the absence of structural defects in the patient’s
brains. In this context it is interesting that BOD1-/- fibroblasts show an increased tolerance to
the PLK1 inhibitor BI2536, which might be explained by the increased localisation of PLK1 to
the centrosomes that we observed. Increased PLK1 at centrosomes may stabilize spindles
allowing mitosis to proceed and preventing structural deficits in the affected tissues.
BOD1 is still expressed throughout adult human brain tissues, in contrast to the cell cycle
kinase PLK1 (Fig 3). This suggests that BOD1 exerts additional functions in mature neurons,
and our observation that Bod1 localises to synapses further supports this notion.
In order to further investigate whether and how loss of BOD1 may affect cognitive function
independent from its mitotic role in cell cycle progression we established Drosophilamodels of
neuronal BOD1 deficiency by knocking down the fly ortholog of BOD1, CG5514, specifically
in postmitotic neurons. All three models show specific deficits in habituation, an evolutionary
conserved form of adaptive learning. Habituation is an important neuronal filtering mecha-
nism, preventing information overload, and a prerequisite for higher cognitive functioning
[43–45]. The Drosophila data thus provide independent evidence for a role of BOD1 in cogni-
tive processes. It is also interesting to note that expression of the PLK1 fly ortholog polo com-
pares well with our finding of very low PLK1 expression in human brain tissues. While
Drosophila polo is expressed in larval neuroblasts [46], polo transcripts seem to be absent in
adult brain [47], supporting an evolutionarily conserved, PLK1-independent postmitotic func-
tion of BOD1 in humans and Drosophila.
The synapse is a key compartment of postmitotic, terminally differentiated neurons that
plays a pivotal role in the maturation and maintenance of cognitive abilities. While the precise
localisation of Bod1 at synapses warrants further investigation, synaptic localisation in mam-
malian neurons and the Drosophila synaptic phenotype upon strong knockdown suggest a
novel role for Bod1 in synapse biology. This assumption is supported by the fact that Drosoph-
ila BOD1 (CG5514) is one of 893 Drosophila genes that were predicted to be involved in syn-
apse assembly and function [48]. Interestingly, it has been shown that functional PP2A
holoenzymes are required for synaptic growth and synaptic function at the Drosophila NMJ
[49]. In view of our finding that BOD1 is required for proper PP2A function in human cells,
this could mean that BOD1 is necessary for appropriate PP2A holoenzyme function and might
thus be involved in the normal development and maintenance of cognitive features. PP2A has
already been implicated in the aetiology of ID. Increased levels of the PP2A catalytic subunit
were found in a cellular model of Fragile X syndrome [50] and PP2A was observed to dephos-
phorylate the Fragile X protein, FMRP, in immediate response to immediate group I metabo-
tropic glutamate receptor (mGluR) stimulation [51]. What is more, putatively causative
missense changes in PP2A subunits were found in several affected individuals from a large
scale study of the genetics of developmental disorders [52] and most recently de novomissense
mutations were identified in B56δ—and Aα—subunit of PP2A in individuals with ID [53].
BOD1 can also be linked to Intellectual Disability through a potential involvement in chro-
matin modification. The protein was recently found associated with SET1B complexes, COM-
PASS-like H3K3 histone methyltransferase multisubunit complexes, also containing HCFC1
[24], implicated in X-linked Intellectual Disability [25,26]. Like homozygous carriers of BOD1
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mutations, individuals affected by HCFC1 mutations show no microcephaly phenotype. Fur-
thermore MLL1, MLL2 and MLL3, the core subunits of other COMPASS complexes that share
a number of subunits with SET1B, and might thus be affected indirectly by loss of BOD1, have
been implicated in ID [54–57].
Although our data strongly indicate a post-mitotic role of Bod1, subtle mitotic defects in
neurogenesis may also contribute to the cognitive impairment of individuals carrying BOD1
mutations. For example, orientation of the cleavage plane is known to be important for cell fate
choice during neurogenesis and development of the neural tube [58–60]. Accelerated progres-
sion into anaphase, analogous to those observed in BOD1-/- Fibroblasts, may interfere with the
correct positioning of the cleavage plane and lead to abnormalities in the generation of the cor-
rect proportions of neurons and progenitors.
Taken together our results identified homozygous loss of BOD1 as a novel cause of ID and
revealed a so far unappreciated postmitotic, likely synaptic function of BOD1. Thus our work
opens up interesting avenues of research into the function of centrosomal proteins in fully dif-
ferentiated neurons.
Materials and Methods
Ethics statement
The ID study was performed in agreement with the approval (2100) of the ethics committee of
the Charité University Medicine Berlin ("Ethikkommission der Charité—Universitätsmedizin
Berlin"), Germany. Written consent for the intellectually disabled individuals was provided by
their parents.
Sample collection, DNA and cell line preparation
The pedigree of the family reported here is shown in Fig 1A. Blood samples for DNA prepara-
tion were collected from the parents and all children of both branches and genomic DNA was
extracted using a standard method. For the index patient (V:2), Fragile X was excluded by PCR
and Southern blot analysis. Filter-dried blood of the index patient was screened by tandem
mass spectrometry to exclude disorders of the amino acid, fatty acid (e.g. phenylketonuria) or
organic acid metabolism [61,62]. Standard 450 G-band karyotyping was performed in order to
exclude cytogenetically visible chromosomal aberrations.
An additional blood sample from patient V:2 was used to establish an EBV transformed
lymphoblastoid cell line and skin biopsies were taken from individuals V:2 and V:3 to isolate
and culture fibroblast cells.
Whole genome linkage analysis and mutation screening
Genotyping was performed with Human Mapping 10K Array Version 2 (Affymetrix). Multi-
point parametric linkage analysis was performed using Allegro [63] applying an autosomal
recessive pattern of inheritance and disease allele frequency of 0.001. Sanger sequencing was
performed and the whole coding and exon-flanking regions in the interval were screened (The
primer sequences are available upon request). The resulting sequences were analyzed using the
CodonCode aligner software.
mRNA assays
Total RNA from the fibroblast and EBV transformed lymphoblast cultures was isolated by
using TRIzol reagent RNA extraction protocol (Invitrogen). In addition, commercially avail-
able RNA (BioCat) was used from various tissues as indicated in Fig 3.
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Semiquantitative RT-PCR was performed in two steps, after Dnase treatment of the RNA
with RQ1 RNase-Free DNase (Promega), cDNA was synthesized with SuperScriptIII reverse
transcriptase kit (Invitrogen) together with random hexamers and followed by Polymerase Chain
Reaction for 35 cycles with primers in both sides of the gene (Forward primer:CATCGTGGAG-
CAGCTCAAG and Reverse primer:GCACTCTTATGTAACCGAATC) to amplify all the possi-
ble splice variants. Subsequently each of the splice variants were verified by isoform specific
RT-PCR (The primer sequences are available upon request) as well as Sanger sequencing.
Isoform specific quantitative PCR was performed in 20 μl volumes and carried out in the
ABI PRISM 7900 HT Sequence Detection System using a 96-well format. Cycling parameters:
10 min at 95oC followed by 40 cycles of 15s 95oC and 1 min 55oC. Amplification plot and pre-
dicted threshold cycle (Ct) values were obtained with the sequence Detection Software (SDS
2.1, PE Applied Biosystems).
We used absolute quantification to quantify unknown samples by interpolating their quan-
tity from a standard curve. To construct the standard curve four-fold dilutions (1, 0.5, 0.25,
0.125) of a total RNA preparation from control cDNA were used. Negative controls (“no tem-
plate control”, NTC) were used to verify amplification quality and to exclude contamination or
primer-dimer artifacts. The gene used for normalising expression was GAPDH.
NMD analysis
The fibroblast cells from two individuals affected by ID (V:2 and V:3) and two controls were
cultured into two sister flasks, one treated with cycloheximide (CHX) (Sigma) at the concentra-
tion of 500 μg/ml and the other one non-treated (just added DMSO). After 7.5 hrs of incuba-
tion in 37C / 5%CO2, the cells were harvested, RNA was extracted and isoform specific
quantitative PCRs were carried out.
Cell lines and cell culture
HeLa S3 cells were maintained in EMEM (Lonza), Primary Fibroblasts were maintained in
Quantum 333 media (PAA) or FibroPlus 333 (Capricorn-Scientific) and EBV-transformed
lymphoblasts were maintained in RPMI 1640 media (Gibco). All media was supplemented
with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 ug/ml streptomycin. Quantum
333 and FibroPlus 333 media was also supplemented with 10 ng/ml bFGF (Cell Signalling
Technology). Cell lines were maintained at 37°C with 5% CO2 in a humidified incubator.
Fibroblast cell lines were electroporated using the Neon Transfection system (Life Technol-
ogies) as per the manufacturer’s instructions using a single pulse of 20 ms and 1600 V. Medium
GC content control siRNA and BOD1 Stealth siRNA (5’-GCCACAAAUAGAACGAG-
CAAUUCAU-3’) were supplied by Life Technologies. The specificity of these reagents and
absence of off-target effects were reported previously [16,17]. Briefly, BOD1 Stealth siRNA
does not target Bod1L or Bod1L2 mRNA and all phenotypes associated with the BOD1 Stealth
siRNA can be rescued using exogenous siRNA-resistant BOD1 expression constructs.
Unless otherwise indicated RO3306 was used at 9 μM, Monastrol at 100 nM and BI 2536 at
12.5 to 200 nM.
Human fibroblast immunostainings and microscopy
Time-lapse imaging and fluorescence microscopy was performed as described [16]. Non-
adherent lymphoblast cells were gently centrifuged onto the surface of a Labtek imaging cham-
ber and constricted close to the coverslip surface by the addition of 50% Matrigel (BD Biosci-
ences). During DIC timelapse imaging of lymphoblast and fibroblast cell lines 10 z sections,
3 μm apart were taken every 4 min for 18 hr on a DeltaVision Spectris (Applied Precision)
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fitted with an environment chamber (Solent) maintained at 37°C. All images were stored and
manipulated using OMERO [64] or Photoshop (Adobe). Images were quantified using
OMERO and m-tools as described [17]. Statistical significance was determined using Mann-
Whitney Rank Sum Tests. Nuclear envelope breakdown (NEB) was defined as the time when a
clear delineation of the nuclear envelope was no longer visible and the volume occupied by
chromosomes began to expand. While not an exact measure of NEB, this approach combined
with the 4 min interval between images provided sufficient accuracy to reveal differences in
mitotic timing in these cell lines.
Rabbit anti-BOD1 [16] and mouse anti-B56α (BD Biosciences) were used at 1:100. Mouse
anti-PLK1 (Upstate), and alpha-tubulin (Sigma) were used at 1:500. Human ACA (CREST)
autoantisera (a kind gift from Sara Marshall, Ninewells Hospital, Dundee), were used at
1:1000. All fluorescently labelled secondary antibodies were obtained from Jackson ImmunoR-
esearch Laboratories.
RNA-sequencing
RNA Expression profiling was carried out on a SOLiD5500XL Sequencing platform as previ-
ously described [65], using RNA preparations form human embryonic stem cells (hES),
induced pluripotent stem cells (iPSC) and commercially available RNA (BioCat) from various
adult brain tissues as indicated in Fig 3.
Isolation of murine primary corticoneuronal cells
The cortex was extracted from mouse embryonic brain at an age of E14.5. One day prior to
sacrificing the mother plates were prepared as follows: Sterilized cover slips were placed tissue
culture wells (12-well plates). The wells were then coated by incubating them for 30 min at
room temperature or over night at 4°C with poly-D-Lysine/Laminin (poly-D-lysine 1:500 and
laminin 1:50 in PBS, 1 ml per well). The wells were then washed twice with 1 ml PBS before
adding 2 ml neurobasal medium to each well and then incubating at 37°C (8% CO2).
The pregnant mother was sacrificed by neck fracture, then the embryos were removed from
the womb and placed in a sterile Petri dish containing PBS.
The preparation of corticoneuronal cells was carried out on a sterile flow bench. Embryos
were briefly washed with PBS and then transferred in a fresh dry Petridish. Next the heads
were removed and the brains excised. The brains were suspended in 1–2 ml DMEM, each. The
Brain stem and brain lobes were separated under a stereoscope and the cortex removed, taking
care to separate the cortex from the hippocampus. Cortex halves were then transferred in a
chilled DMEM-Tube on ice. Next, single cells from isolated embryonic cortices were prepared:
5 ml trypsin was added and incubated for 7 min at 37°C (5%CO2), swirling once in between.
Trypsin activity was then stopped by adding DMEM + 10% FCS and centrifugation (200xg for
3 min). This step was repeated twice. Finally the DMEM was carefully removed and 2 ml neu-
robasal medium were added, before decollating the cells using a narrowed pasteur pipette.
Cells were then diluted by adding 28 ml neurobasal medium, counted and seeded to a density
of 1.5x105 cells per cm2 in the prepared 12 well plates. After approximately 1 hr of incubation
at 37°C (8% CO2) the medium was changed in order to remove unwanted cells. The next
change of medium was after day 3–4. Subsequently the medium was changed every 7th day. On
the 7th day after seeding (or later) cells were used for experimental applications.
Transient transfection of murine primary cortical neurons
Cells were transfected by pEGFP-BOD1 (wt) or pEGFP-N1 vector (Control) at days 7 and 9
after preparation. A solution-A (containing 0.1 μg of plasmid DNA and 100 μl OptiMEM), and
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a solution-B (with 2 μl lipofectamine and 100 μl OptiMEM) were prepared and kept for 5 min
at room temperature. Subsequently, solutions were mixed and incubated at room temperature
for 20 min. Meanwhile, cell culture medium was replaced by transfection medium (antibiotic
free culture medium). The transfection mixture was slowly added to the cells which then were
incubated at 37°C (8% CO2). On both days cells were fixed with PFA 4% at two time points (6
and 8 hr).
Fly stocks
Fly stocks were kept on standard Drosophila diet (cornmeal/sugar/yeast) at 25°C, in a12h:12h
light/dark cycle. For the habituation experiments, flies were reared and tested at 25°C and 70%
humidity, 28°C and 60% humidity was used during synapse morphology experiments and to
generate ubiquitous RNAi-mediated knockdown for quantitative PCR (qPCR). Inducible
RNAi lines against the BOD1 Drosophila ortholog CG5514 (vdrc105166, vdrc27445) and their
corresponding genetic background control lines (vdrc60100, vdrc60000) were obtained from
Vienna Drosophila RNAi Center [66]. A nonsense RNAi line, targeting a C.elegans-specific
gene, was obtained from K. Keleman. Inducible short-hairpin RNAi line HMS00720
(BL32928) and its corresponding genetic background control line y v; attP2, y+ (BL36303),
generated by Transgenic RNAi Project (TRiP), were obtained from Bloomington Drosophila
Stock Center. The ubiquitous actin-Gal4 driver w1118; P(w[+mC] = Act5c-Gal4)/CyO, also
obtained from Bloomington Drosophila Stock Center, was used to generate RNAi-mediated
knockdown for qPCR. In-house assembled panneuronal elav-Gal4 driver lines were used for
habituation (2xGMR-wIR; elav-Gal4, UAS-Dicer2)) and synapse morphology experiments
(UAS-Dicer2; elav-Gal4). In all experiments, progeny of a cross between these Gal4-driver
lines and the genetic background of the respective RNAi line was used as a control.
Light-off jump habituation
The light-off jump habituation assay was performed as previously described [32] with minor
adaptations. Briefly, 3–7 day old individual male flies (Bod1vdrc105166, Bod1HMS00720) or female
virgin flies (Bod1vdrc24445) were tested for jump responses in two independent 16-unit light-off
jump habituation systems. 32 flies (16-flies/system) were simultaneously exposed to series of
100 short (15ms) light-off pulses with a 1s interval between the pulses. The noise amplitude of
wing vibration following every jump response was recorded for 500ms after the start of pulse
and a carefully determined threshold was applied to annotate jump responses. Data were col-
lected and analyzed by custom-made Labview Software (National Instruments). High initial
jumping response to light-off pulse decreased with growing number of pulses and flies were
considered habituated when they failed to jump in 5 consecutive trials (non-jump criterion).
Habituation was scored as the number of trials required to reach the non-jump criterion (Trials
To Criterion, TTC). Main effects of genotype (mutant vs control), day and system on log trans-
formed TTC values were tested using linear model regression analysis (lm) in R statistical soft-
ware (R version 3.0.0 (2013-04-03)). A nonsense RNAi line targeting a C.elegans-specific gene
(KK library construct) was also tested and did not affect habituation.
Analysis of CG5514mRNA levels from whole Drosophila larvae by
qPCR
Total RNA from 3rd instar larvae (3 biological replicates) was isolated using RNeasy Lipid Tis-
sue Mini Kit (Qiagen). During the isolation procedure, samples were treated with RNase-free
DNase Set (Qiagen). RNA isolated from Bod1HMS00720 and its respective genetic background
control was used directly for cDNA synthesis. RNA isolated from Bod1vdrc105166 and its
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respective genetic background control was further processed by Oligotex mRNAMini Kit and
purified PolyA+ RNA was used for cDNA synthesis. First strand cDNA synthesis was per-
formed using iScript cDNA Synthesis Kit (Biorad). Gene expression was analysed by real-time
PCR (7900HT Fast Real-Time PCR system, Applied Biosystems). PCR reactions were per-
formed in a volume of 25μl containing 150 nM primers and GoTag Green Mastermix (Pro-
mega). Primer sequences used for amplification of CG5514: 5’-ACAACAGTGGGGAGCCA
G-3’ and 5’- CCTGTGCTAGTCGTCTCCG-3’. The amplicon spans the HMS00720 cleave site
and should effectively detect the initial cleavage step of RNA interference. To determine the
efficiency of the initial cleavage step of long vdrc105166 siRNA hairpin, the primers were
designed to detect the region within the 5’ cleavage fragment, and qPCR was perfomed on
PolyA+ mRNA. This ensures that in case of successful initial cleavage, regions 5’ to the cleavage
site would not be amplified in qPCR reaction [67]. Pol II was used as reference gene, primer
sequences: 5’- TCAGAGTCCGCGTAACACC-3’, 5’- TGGTCACAAGTGGCTTCATC-3’.
Analysis of synaptic morphology
Wandering L3 larvae were dissected and fixed in 3.7% paraformaldehyde for 30 minutes.
Males were selected for Bod1vdrc105166 and female larvae for the X-linked Bod1vdrc24445. Type
1b neuromuscular junctions (NMJs) at muscle 4 were visualized using the primary antibody
anti-dlg1 (1:25, Developmental Studies Hybridoma Bank) in combination with the Zenon
Alexa Fluor 568 Mouse IgG1 labelling kit (Invitrogen). NMJ images were acquired using a
Leica automated high-content microscope. Individual synapses of segments A2 –A5 were
imaged and quantified using an in-house developed Fiji-compatible macro. Synaptic parame-
ters were compared between the RNAi line and the corresponding genetic background control
line using a student’s T-test.
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